1
/
of
0
FDA Drug Approval, A209356, SUCRALFATE
FDA Drug Approval, A209356, SUCRALFATE
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
ANDA: 209356
Company: AMNEAL
Drug Name: SUCRALFATE
Active Ingredients: SUCRALFATE
Strength: 1GM/10ML
Dosage Form/Route: SUSPENSION;ORAL
Action Date: 12/02/2019
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Company: AMNEAL
Drug Name: SUCRALFATE
Active Ingredients: SUCRALFATE
Strength: 1GM/10ML
Dosage Form/Route: SUSPENSION;ORAL
Action Date: 12/02/2019
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details